T
he potential contribution nurses can make to the management of antimicrobials within an in-patient setting could impact on the development of antimicrobial resistance (AMR) and healthcare associated infections (HCAIs). Current initiatives promoting prudent antimicrobial prescribing and management have generally failed to include nurses, which subsequently limits the extent to which these strategies can improve patient outcomes. For antimicrobial stewardship (AS) programmes to be successful, a sustained and seamless level of monitoring and decision making in relation to antimicrobial therapy is needed. As nurses have the most consistent presence as patient carers, they are in the ideal position to provide this level of service. However, for nurses to truly impact on AMR and HCAIs through increasing their profi le in AS, barriers and facilitators to adopting this enhanced role must be contextualised in the implementation of any initiative.
Over the past decade, there has been an increase in the prevalence of micro-organisms that are resistant to antimicrobial treatment. Antimicrobial resistance (AMR) is an increasing problem that limits and complicates treatment of infections -particularly in hospitals ( MacDougall and Polk, 2005 ) . Initiatives have been implemented within acute care settings to promote prudent antibiotic prescribing that have primarily targeted the practices of pharmacists and doctors within this context. Very little consideration has been afforded to the contribution nurses can make to the management of antimicrobials and how this may impact the development of AMR and healthcare associated infections (HCAIs). Herein we further discuss the problem and explore the extent to which nurses could contribute to the management of antimicrobials within an in-patient setting, while considering the diffi culties inherent in introducing a new realm of responsibility to a workforce already challenged in time and resources.
The impact of antimicrobial therapy on acute healthcare Excessive and indiscriminate use of antimicrobials in acute care settings contributes to the emergence and dissemination of antimicrobial resistant organisms, such as Meticillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci (VRE) ( Dancer, 2008 ; Taconelli et al, 2008 ) . The spread of New Delhi metallo-β -lactamase (NDM) from the Asian subcontinent to Europe is just one recent reminder of the continuing evolution of AMR. This highlights potential for the spread of resistant organisms globally, promulgated by the connectivity of the world through air travel, and particularly through emerging trends in treatment options in the form of 'medical tourism' ( Kumarasamy et al, 2010 ) . Thus the UK is not only vulnerable to AMR emerging as a result of local suboptimal practice, but also to the ramifi cations of poor antimicrobial management internationally.
Inappropriate antimicrobial use also results in an increased prevalence of HCAIs, such as Clostridium diffi cile infection (CDI) ( Barbut and Petit, 2001 ; Bartlet, 2008 ) . More than 90% of CDI occurs following or during treatment with antibiotics, with CDI disproportionately affecting elderly patients ( Barbut and Petit, 2001 ; Weston, 2008 ) . Signifi cant problems relating to antimicrobial therapy emerge in hospitals as many patients receive antimicrobials and are often highly susceptible to infections due to complex, severe illness and compromised immunity. When infections present in a single patient they can be transmitted to other patients and ultimately become endemic in hospital settings ( Weston, 2008 ) . Furthermore, HCAIs caused by resistant organisms are associated with increased morbidity and mortality, and a longer hospital stay compared with infections caused by more sensitive organisms ( Cosgrove, 2006 ; Owens et al, 2008 ) . The impact of HCAIs such as MRSA and CDI on patients' experience of Covering more territory to fi ght resistance: considering nurses' role in antimicrobial stewardship healthcare has been profound, with infection rates being one of the primary concerns of individuals being admitted to hospital ( Department of Health, 2004 ) .
Increased monitoring of antimicrobials combined with optimisation of antibiotic prescribing and infection prevention and control strategies, have been shown to reduce HCAIs ( Dubberke et al, 2008 ) . Further, judicious selection of antimicrobials and appropriate duration of therapy slows or prevents the emergence of resistant organisms ( Davey et al, 2005 ) . Antimicrobial prescribing and management choices involve a multidimensional decision making process based on a fundamental understanding of the key principles of microbiology and the ramifi cations of inappropriate antibiotic use ( Charani et al, 2010 ) . However it is estimated that between 25%-68% of antibiotic use in hospitals is inappropriate ( Dunagan et al, 1989 ; House of Lords, 1998 ; Behar et al, 2000 ; Willemsen et al, 2007 ) , with many aspects of antimicrobial management having an impact on the emergence of AMR, HCAIs and patient outcomes. In addition to this, the highest incidence of medication errors occur during the administration of antibiotics . Considering the link between the inappropriate use of antibiotics and the development of drug-resistant organisms and CDI, it is imperative that systems are implemented to optimise antimicrobial use in hospitals to decrease HCAIs and increase patient safety.
Nurses' role in antimicrobial stewardship
Preventing further emergence of AMR depends on optimising use of antimicrobials through such activities as ensuring the agents used to treat infection are as specifi c as possible; courses of antibiotics being stopped at the earliest opportunity; oral rather than intravenous route of administration being used whenever appropriate; and some antibiotics being avoided in hospital settings ( Knox et al, 2002 ; MacDougall and Polk, 2005 ) . Antimicrobial stewardship (AS) has been described as a multidisciplinary approach to minimising the development of AMR through selection of appropriate antimicrobials, optimising dose and duration, and minimising toxicity and side effects ( Knox et al, 2002 ; MacDougall and Polk, 2005 ) . Antimicrobial stewardship programmes (ASP) have been implemented throughout many UK hospitals, and although they are described as multidisciplinary in approach, nurse involvement in AS has been limited. AS teams have primarily included infectious disease physicians, clinical or infectious disease pharmacists, clinical microbiologists, and epidemiologists ( Lesprit and Brun-Buisson, 2008 ) , and there is currently a lack of recognition of how nurses can contribute to the reduction of HCAIs and AMR through participation in ASP. It has been suggested that AS teams collaborate with infection control teams, including infection control nurses, however this is primarily for multidisciplinary data exchange ( MacDougall and Polk, 2005 ) , and the potential contribution nurses can make to the management of antimicrobials on the ward remains under-explored.
Currently, elements of AS such as monitoring duration and indication for antimicrobial treatment, instigating prompt de-escalation from intravenous to oral therapy, monitoring for drug allergies and side effects, monitoring therapeutic levels, ensuring timely administration of antimicrobials and following up on missed doses have primarily fallen into the work remit of physicians and pharmacists. However, owing to time constraints, workload and high staff rotation, it may be diffi cult for these activities to be performed consistently. Nurses work at multiple levels within the clinical setting, playing a key role in patient safety and have the most consistent presence as patient carers. With review of medication charts being part of routine professional practice and as the primary healthcare workers within the hospital setting to administer medications, nurses are in a key position to collaborate with AS teams and contribute to the multidisciplinary management of antimicrobials throughout acute care settings. Table 1 highlights some of the areas of antimicrobial management that nurses could impact upon, thus potentially making a valuable contribution to AS. Yet omission of nurses from decision making processes about antimicrobial therapy has limited the extent to which nurses may infl uence outcomes. In particular, antibiotic treatment decision making on general ward rounds, or on rounds targeted specifi cally at reviewing antimicrobial therapy are opportunities for nurses to make a contribution. Ward rounds can result in cooperative decision making between nurses and other healthcare colleagues ( Beuscart-Zephir et al, 2005 ) , and although generally not directly involved in prescribing, nurses can infl uence the decision making of medical and other prescribers through, for example, encouraging medication compliance, monitoring prescription decisions and reducing prescribing errors ( Castledine, 2006 ; Jutel and Menkes, 2010 ) . Nurse involvement in ward rounds could provide nurses, physicians and pharmacists with a venue for prompt dialogue to discuss antimicrobial treatment, indication, and duration, thus further enhancing the multidisciplinary management of AS to reinforce best practice. Ward nurses are also in a key position to facilitate patient referrals for outpatient antibiotic therapy in instances where patient admission to hospital is for extended antibiotic therapy only. This proactive approach to patient care could reduce patients' length of stay, thus decreasing their risk of HCAIs and associated costs, and enabling the patient to continue treatment in their own environment.
A collaborative approach to antimicrobial management
Nurses have already demonstrated that they can have a positive impact on patient outcomes in other specialty areas such as pain management, which in the past has been heavily based on medication use. Nurse introduction of non-pharmacological and patient education approaches to reduce pain has subsequently decreased patients' reliance on medications ( Wells-Federman et al, 2002 ) . It is possible that initiatives focused on increasing nurses' participation in antimicrobial management activities can yield similar success. Although in the past there has been a focus on expanding the prescribing authority of nurses, which has become emblematic of professional autonomy, it may be more appropriate to look at the infl uence nurses may have in the management of drugs ( Jutel and Menkes, 2010 ) , and how this can be channelled to enhance AS.
Participation in the multidisciplinary management of antimicrobials would provide an avenue through which nurses could be more effective patient advocates. As specifi ed in the UK Code of Conduct for Nurses ( Nursing and Midwifery Council, 2007 ) , nurses have an obligation to be patient advocates, ensuring that those in their care have access to relevant health care, information and support. As part of this function, the appropriate management and administration of antimicrobials is enshrined in nursing practice, and as such, nurses have a responsibility to ensure that antimicrobials are used appropriately, that administration of antimicrobials occurs in accordance with the treatment plan, and that any variations are acted on promptly to ensure optimal therapy. However, nurses' exclusion from ASP has created an environment in which antimicrobial management is considered to be outside the remit of nursing responsibilities and expertise, which essentially has disempowered healthcare institutions from taking a true multidisciplinary approach to optimising antimicrobial use.
Although the value in bringing together the expertise and experience of a variety of healthcare professionals may seem apparent, interprofessional collaboration is increasingly becoming a complex concept often marred by unclear working methods and a lack of understanding about how to translate knowledge into practice ( San Martin-Rodriguez, 2005 ). However, it is understood that a hospital's success and patient outcomes are strongly dependent on how effectively the members work together as a team ( Rafferty et al, 2001 ; Leonard et al, 2004 ) . Therefore, it is likely that effective monitoring and direct communication between healthcare professionals, including nurses, regarding antimicrobial use would promote best practice, improve patient care and reduce nurses' workload. Specifi cally, these activities are likely to contribute to reducing the risk of CDI and HCAIs associated with antimicrobial use, thus decreasing patient morbidity and mortality, reducing length of stay and improving patient experience of health care.
Although it is recognised that expertise is required to manage antimicrobial treatment, in reality the decision making process is often performed by junior doctors working outside their area of expertise with varying levels of senior support ( Charani et al, 2010 ) . The high rotation of junior doctors throughout wards means that a repository for local knowledge about the management of antimicrobials for specifi c patient groups is lost. Prescribing and management of antimicrobials occurs across all areas of healthcare and does not sit within a particular specialty, and as such the memory of the healthcare organisation suffers. Organisational memory refers to the retrievable information contained within an organisation in formats such as spreadsheets and guidelines as well as in the minds of the organisation members ( Paoli and Prencipe, 2003 ) . As one of the less transient professional populations within the hospital, nurses are in an ideal position to contribute to organisational memory regarding antimicrobial management. In collaboration with physicians and pharmacists, nurses' local knowledge could assist in informing decision choices in relation to antimicrobial therapy, and enhance the multidisciplinary approach to antimicrobial management.
For ASP to continue to be successful, a sustained and seamless level of monitoring and decision making in relation to antimicrobial therapy is needed, and as the most consistent provider of care at the bedside, nurses are in the ideal position to provide this level of service. However, all nurses may not have the required training or profi le among peers and other medical staff to actively contribute to antimicrobial management. Additionally, nursing shortages may impose Use of broad spectrum antibiotics is a major contributory factor to developing CDI and AMR. Broad spectrum antibiotics should be avoided when possible ( Lespirit and Brun-Buisson, 2008 ) .
Additional support and training of nurses could ensure treatment is in line with microbiology results, and use of broad spectrum antimicrobials is limited where possible.
Duration of treatment
Prolonged duration of antimicrobial treatment is a risk factor for development of CDI, and may increase AMR ( Knox et al, 2002 ; MacDougall and Polk, 2005 ; Lespirit and Brun-Buisson, 2008 ) In collaboration with doctors and pharmacists, nurses can ensure antimicrobials are prescribed for appropriate duration.
Route of antimicrobial administration
Early switching from intravenous antimicrobial therapy to oral treatment decreases length of hospital stay, reduces risk of AMR and decreases workload on nurses ( Oosterheert et al, 2006 ; Mertz et al, 2009 ) Nurses can monitor IV antimicrobial prescriptions and engage physicians and pharmacists in discussion regarding de-escalation to oral therapy.
Surgical prophylaxis
Timing of administration and duration of surgical prophylaxis often occurs outside best-practice guidelines ( Bratzler et al, 2005 ) which decreases impact on post-surgical infections and increases AMR ( Harbarth et al, 2000 ) Through collaboration with doctors and pharmacists, nurses can ensure antimicrobials are prescribed for appropriate duration.
Timing of antimicrobial administration
Prompt and timely administration of antimicrobials may be associated with increased survival to hospital discharge ( Kumar et al, 2006 ) .
Through increasing nurses' awareness and training in antimicrobial stewardship programmes, it is likely that antimicrobial administration practices will improve. Therapeutic drug monitoring Sub-optimal antibiotic concentrations contribute to the development of AMR ( Thomas et al, 1998 ) . Therapeutic drug monitoring should occur for antibiotics that perform optimally within a specifi c 'therapeutic level', and prescriptions titrated accordingly.
Nurses could contribute through monitoring of blood results and working with physicians to ensure doses are in line with recommended guidance.
Outpatient antibiotic therapy (OPAT)
OPAT decreases patients' length of stay in hospital, reduces risks for transmission of healthcare associated infections and decreases associated costs ( Gilchrist et al, 2008 ; Hitchcock et al, 2009 ) .
Engaging nurses in decision making regarding a patient's suitability for OPAT may result in more proactive and effi cient use of this service and improve associated outcomes. CDI: Clostridium diffi cile infection; AMR: Antimicrobial resistance. time constraints that prohibit any additional duties into nurses' work regimes. It is therefore important to fi rst assess the feasibility of increasing nurses' participation in AS. It is necessary to identify what role nurses currently have in relation to the management of antimicrobials, and where this could be developed in the future.
Contextual challenges in the multidisciplinary management of antimicrobials
Assumptions that healthcare professionals have the time, resources, knowledge, motivation and skills to change clinical practice in line with evidence-based recommendations are counterproductive. Historically, interventions that focused on changing the behaviours of healthcare professionals have had limited success ( Cook et al, 2000 ; Pittet, 2004 ; Ferlie et al, 2005 ) , especially if not implemented with an understanding of the cultural, contextual and environmental infl uences on professional practice. In order to more successfully engage healthcare workers in initiatives and produce more successful outcomes, the obstacles and facilitators to changing or adopting new practice must be considered in the development and implementation of any programme ( Hulscher et al, 2010 ) . Therefore, for nurses to truly have an impact on AMR and HCAIs through increasing their profi le in AS, barriers and facilitators to adopting this enhanced role must be contextualised. Furthermore, a clear understanding of nurses' roles, and clarity among healthcare professionals of where responsibilities lie, will assist with cohesiveness among multidisciplinary teams.
It would be remiss not to acknowledge the professional challenges that may be presented when attempting to enhance nurses' role in antimicrobial management. Nurses' ability to discuss or even challenge antimicrobial management choices is heavily connected to the construct of power and knowledge, particularly within the acute care context. Nurses may not feel they are in a position to participate in ASP due to lack of knowledge, closely linked to positions of power, particularly within healthcare environments ( Hindess, 1996 ) . The challenges associated with infl uencing antimicrobial management decisions are further complicated through prescribing etiquette, which refers to prescribers' reluctance to change colleagues' decisions ). Indeed, one could argue that moving away from the persistent use of the term 'antimicrobial prescribing' to antimicrobial management would facilitate a more inclusive approach. The term 'prescribing' relates to a specifi c area of expertise associated primarily with the practice of doctors and pharmacists, eliminating nursing from the decision making process. Acknowledging that it is the management of antimicrobials that leads to the emergence of AMR and HCAIs could facilitate a more holistic approach to ensuring antimicrobials are used appropriately and could facilitate nurses' involvement in ASP.
Conclusion
Given the increasing social and economic burden of AMR and HCAIs, it is critical that healthcare professionals increase their efforts to work together across disciplines for the protection and safety of their patients. The implementation of ASP within the UK has been effective in promoting prudent antimicrobial prescribing, however the extent to which nurses can contribute to such initiatives is poorly understood. As the most consistent providers of care at the bedside, and because medication chart review is part of their routine professional practice, nurses are in an ideal position to enhance antimicrobial management through multidisciplinary collaboration. Increasing nurses' awareness of antimicrobial use and the impact of antibiotic therapy on infection outcomes is likely to enhance the optimisation of antimicrobial treatment, monitoring and administration. Nurse involvement in AS could therefore be a time-and cost-effi cient use of resources while improving patient safety and quality of care. As pharmacological options for the treatment of infection decrease, and development of new antimicrobials is slow, it is imperative that initiatives to reduce AMR are implemented. For these initiatives to positively and sustainably impact on outcomes, it is necessary to gain a contextual understanding of the barriers and facilitators to nurses contributing to AS, and how this aspect of the nursing role may be developed in the future.
